Introduction to Sars Cov 2 N
Sentence Examples
Discover more insights into Sars Cov 2 N
Keywords frequently search together with Sars Cov 2 N
Narrow sentence examples with built-in keyword filters
Sars Cov 2 N sentence examples within receptor binding domain
Antibodies against the SARS-CoV-2 nucleocapsid and the receptor binding domain of the S1 subunit of the spike protein were measured in all individuals at different time points.
Full Text
We evaluated the durability of IgG responses specific to SARS-CoV-2 nucleocapsid (N), receptor binding domain (RBD), and spike (S) antigens in saliva up to 8 months after RT-PCR-confirmed COVID-19 using a multiplex salivary assay.
Full Text
Sars Cov 2 N sentence examples within coronavirus disease 2019
Since universal vaccination is a pillar against coronavirus disease 2019 (COVID-19), monitoring anti-SARS-CoV-2 neutralizing antibodies is essential for deciphering post-vaccination immune response.
Full Text
Objectives Since universal vaccination is a pillar against coronavirus disease 2019 (COVID-19), monitoring anti-SARS-CoV-2 neutralizing antibodies is essential for deciphering post-vaccination immune response.
Full Text
Sars Cov 2 N sentence examples within acid amplification test
Among 236 SARS-CoV-2 nucleic acid amplification test-positive and 576 test-negative participants aged [≥]16 years, VE of mRNA vaccines against COVID-19 was 91% (95% CI: 83-95) for full vaccination and 75% (95% CI: 55-87) for partial vaccination.
Full Text
We estimated the distributions of duration of SARS-CoV-2 nucleic acid shedding and time to reinfection among 137 persons with at least two positive nucleic acid amplification test (NAAT) results from March to September 2020.
Full Text
Learn more from Sars Cov 2 N
Sars Cov 2 N sentence examples within polymerase chain reaction
Sars Cov 2 N sentence examples within enzyme linked immunosorbent
In this paper, we demonstrate the significant impact of dimerization of SARS-CoV-2 nucleocapsid protein on sensitivity of enzyme-linked immunosorbent assay (ELISA) based diagnostics of COVID-19.
Full Text
Here, we compared SARS-CoV-2 nucleocapsid antigen (N-Ag) testing using an enzyme-linked immunosorbent assay (ELISA) with SARS-CoV-2 RNA detection.
Full Text
Sars Cov 2 N sentence examples within 2 spike protein
Targeting the E484 codon of the SARS-CoV-2 Spike protein, E-beacons (80 × 10−12 M) reported wild-type SARS-CoV-2 nucleic acid at ≥1 × 10−9 M with increased bioluminescence of 8-fold.
Full Text
In particular, presented here are virtually screened polyphenolic compounds which showed potential as either antagonists to viral entry and host cell recognition through binding with various receptor-binding regions of SARS-CoV-2 spike protein or as inhibitors of viral replication and post-translational modifications through binding with essential SARS-CoV-2 non-structural proteins.
Full Text
Sars Cov 2 N sentence examples within angiotensin converting enzyme
We demonstrate how this assay can be implemented as a rapid surrogate assay for functional cell-based serological methods to measure the SARS-CoV-2 neutralizing capacity of antibodies at the angiotensin-converting enzyme 2–RBD (ACE2-RBD) interface.
Full Text
Methods
: Forty seven nasopharyngeal swab (NPS) specimens from 25 SARS-CoV-2 infected patients and 22 SARS-CoV-2 negative individuals were investigated for expression of toll-like receptors (TLRs), melanoma differentiation-associated protein 5 (MDA5), NOD-like receptors family pyrin domain containing 3 (NLRP3), angiotensin-converting enzyme 2 (ACE2), interleukin (IL) - 6, tumour necrosis factor alpha (TNFα) and type-1 interferons (IFNs) by real time reverse transcription polymerase chain reaction.
Full Text
Sars Cov 2 N sentence examples within spike receptor binding
We found that 7-8 months after the infection their antibodies to SARS-CoV-2 Nucleocapsid (N) protein declined whereas we found no decrease in the antibodies to Spike receptor-binding domain (S-RBD) when compared to the findings at seropositivity identification.
Full Text
Two FDA-approved immunoassays against SARS-CoV-2 Nucleocapsid protein(NCP) and anti-spike-receptor binding domain(S-RBD) were used for sequential serological tests at different time points.
Full Text
Sars Cov 2 N sentence examples within severe acute respiratory
Among a clinical laboratory that has been conducting routine workforce screening since the beginning of the pandemic, we aimed to assess the relative risk of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection among individuals who were SARS-CoV-2 naive, previously infected, or vaccinated.
Full Text
At the same time, many laboratories have shifted focus to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) research and diagnostic development, leading to large-scale production of SARS-CoV-2 nucleic acids that can interfere with these tests.
Full Text
Sars Cov 2 N sentence examples within reverse transcription polymerase
Reverse transcription polymerase chain reaction (RT-PCR) of SARS-CoV-2 nucleic acid was positive and chest X-ray performed in the Emergency Department showed bilateral subpleural opacities in all.
Full Text
Because of the clinical features and the COVID-19 pandaemic, a nasopharyngeal swab was used for sampling, and SARS-CoV-2 nucleic acid was detected by reverse transcription polymerase chain reaction (RT-PCR) test.
Full Text
Sars Cov 2 N sentence examples within rapid diagnostic test
The study utilized a lateral flow rapid diagnostic test (RDT) which detected IgM and IgG antibodies against SARS-CoV-2 nucleocapsid protein.
Full Text
The screening was performed using a strip-in-cassette lateral flow type Rapid Diagnostic Test (RDT) kit that simultaneously and separately detected IgM and IgG antibodies against SARS-CoV-2 nucleocapsid protein.
Full Text
Sars Cov 2 N sentence examples within % 95 %
A sensitivity of 100% (95% CI: 86–100%) was achieved in COVID-19 patients 14 days post symptom onset with dual sero-positivity to SARS-CoV-2 N and the receptor-binding domain of the spike protein.
Full Text
Findings
All LFDs showed high specificity (≥98·0%), except for the E25Bio test (86·0% [95% CI 77·9–99·9]), and most tests reliably detected 50 PFU/test (equivalent SARS-CoV-2 N gene Ct value of 23·7, or RNA copy number of 3 × 106/mL).
Full Text
Sars Cov 2 N sentence examples within viral life cycle
Although potential internal modifications have been reported in SARS-CoV-2 RNA, the function of the SARS-CoV-2 N6-methyladenosine (m6A) modification in the viral life cycle is unclear.
Full Text
The complete viral life cycle can be achieved and exclusively confined in the cells ectopically expressing SARS-CoV or SARS-CoV-2 N proteins, but not MERS-CoV N.
Full Text
Sars Cov 2 N sentence examples within acid amplification testing
Nucleic acid amplification testing or gene sequencing can serve as pathogenic evidence of COVID-19 diagnosing for clinically suspected cases, and dynamic monitoring of specific antibodies (IgM, IgA, and IgG) is an effective complement for false-negative detection of SARS-CoV-2 nucleic acid.
Full Text
2% (27/64) of overlooked COVID-19 diagnoses had occurred when case detection had relied solely on SARS-CoV-2 nucleic acid amplification testing.
Full Text
Sars Cov 2 N sentence examples within acid amplified testing
Sars Cov 2 N sentence examples within inhibit viral infection
Most known SARS-CoV-2 neutralizing antibodies (nAbs), including those approved by the FDA for emergency use, inhibit viral infection by targeting the receptor-binding domain (RBD) of the spike (S) protein.
Full Text
Remarkably, many patient-derived antibodies that potently inhibit viral infection harbor few to no mutations from the germline, suggesting that naïve antibody libraries are a viable means for discovery of novel SARS-CoV-2 neutralizing antibodies.
Full Text
Sars Cov 2 N sentence examples within 19 pandemic caused
In the COVID-19 pandemic caused by the SARS-CoV-2 neurotrophic virus, neurologists have focused their attention on the early identification of suggestive manifestations of the neurological impact of the disease.
Full Text
INTRODUCTION
Since the outbreak of the COVID-19 pandemic caused by SARS-CoV-2 novel coronavirus, the international community has been concerned about the emergence of mutations altering some biological properties of the pathogen like increasing its infectivity or virulence.
Full Text
Sars Cov 2 N sentence examples within rapid affinity pair
Here, we demonstrate the use of the rapid affinity pair identification via directed selection (RAPIDS) method to discover multiple affinity pairs for SARS-CoV-2 nucleocapsid protein (N-protein), a biomarker of COVID-19, from in vitro libraries in 10 weeks.
Full Text
Here, we demonstrate the use of the rapid affinity pair identification via directed selection (RAPIDS) method to discover multiple affinity pairs for SARS-CoV-2 nucleocapsid protein (N-protein), a biomarker of COVID-19, from in vitro libraries in 10 weeks.
Full Text
Sars Cov 2 N sentence examples within structural protein 13
Here, we found that SARS-CoV-2 non-structural protein 13 (nsp13) has an inhibitory role in regulating type I interferon production.
Full Text
The SARS-CoV-2 Non-structural protein 13 (NSP13) has been identified as a target for anti-virals due to its high sequence conservation and essential role in viral replication.
Full Text
Sars Cov 2 N sentence examples within da pandemia de
Além da ligação da pandemia de Covid-19 e aumento dos casos de DK, outro período em que houve pico de incidência da DK foi durante o contexto da pandemia de H1N1, sugerindo que o SARS-CoV-2 não é o único vírus capaz de desencadear tal surgimento da doença de Kawasaki.
Full Text
O presente estudo objetivou analisar o impacto da pandemia de coronavírus Sars-CoV-2 nos atendimentos odontológicos à população infantojuvenil na cidade de João Pessoa-PB.
Full Text
Sars Cov 2 N sentence examples within real time reverse
We have implemented an in-house one-step real-time reverse transcription-PCR (qPCR) assay that specifically detects SARS-CoV-2 N501Y.
Full Text
We developed a saliva-based testing pipeline for detection of SARS-CoV-2 nucleic acids using real-time reverse transcription PCR (RT-PCR) and droplet digital PCR (ddPCR) readouts, and measured samples from 137 outpatients tested at a curbside testing facility and 29 inpatients hospitalized for COVID-19.
Full Text
Sars Cov 2 N sentence examples within cross sectional study
Methods and Findings: Data from 460 individuals collected in Spain between April and July 2020 was analyzed in a cross-sectional study: healthy, Sars-Cov-2 negative (group 0, N = 197), Sars-Cov-2 positive, with mild COVID-19 symptoms (group 1, N = 113), Sars-Cov-2 positive, with severe COVID-19 symptoms who required hospitalization (group 2, N = 150) at Hospital Universitario Cruces in Bilbao, Spain.
Full Text
The novel coronavirus (SARS-CoV-2) pandemic, dubbed COVID-19, has become one of the most serious challenges for human populations in the vast majority of countries worldwide Rapid spreading and increased mortality related to it required new approaches to manage epidemic processes on a global scale One of such approaches was based on analyzing SARS-CoV-2 seroprevalence associated with COVID-19 Our aim was to summarize the results on assessing seroprevalence to the SARS-CoV-2 nucleocapsid antigen (Nc) in residents from 26 regions of the Russian Federation, carried out during the first wave of the COVID-19 epidemic Materials and methods Seroprevalence distribution was examined in 26 model regions of the Russian Federation according to the unified method developed by the Rospotrebnadzor with the participation of the Federal State Institution Saint Petersburg Pasteur Research Institute of Epidemiology and Microbiology Such approach implied formation of a group of volunteer subjects in model geographic region who were tested by ELISA for anti-Nc serum antibody level in peripheral blood Analyzed primary data obtained in separate regions were either accepted for publication or released Results The current paper finalizes the data obtained in all 26 regions of the Russian Federation The total SARS-CoV-2 seroprevalence was 19 5 (10 0-25 6)% with the maximum and minimum value found in the Kaliningrad Region and the Republic of Crimea, respectively (50 2% vs 4 3%) A pattern of age-related seroprevalence distribution indicates insignificant predominance of seroprevalence among subjects of 1-17 years old: 22 1 (13 1-31 8)% Among COVID-19 convalescents positive for SARS-CoV Nc antibodies it reached 60 0 (40 0-73 3)% The number of contact persons comprised 6285 subjects or 8 5% of total volunteer cohort, with the level of seroprevalence reaching up to 25 3 (17 95-35 8)% A direct correlation was revealed between levels of seroprevalence in convalescent and contact volunteers In addition, the reproductive number for SARS-CoV was calculated comprising 5 8 (4 3-8 5) suggesting that one convalescent subject can infect at least 4 healthy individuals A high level of asymptomatic forms of COVID-19 among seropositive subjects was confirmed empirically comprising up to 93 6 (87 1-94 9)% Conclusion A single cross-sectional study performed during 2020 June-August timeframe allowed to assess pattern of sex- and age-related COVID-19 seroprevalence for general population in 26 Russian Federation regions The data obtained may serve as a basis for the longitudinal cohort investigation with serial subject sampling The timing and duration of study will be determined by dynamics of ongoing COVID-19 epidemic.
Full Text
Sars Cov 2 N sentence examples within 24 h post
The fluorescent fusion proteins enabled concise visualization of SARS-CoV-2 N in the cytoplasm but not in the nucleus 24 h post infection, akin to the distribution of SARS-CoV N, thereby validating these useful imaging tools.
Full Text
% of infected cells was determined by flow cytometry detecting SARS-CoV-2 nucleocapsid protein 24 h post-infection.
Full Text
Sars Cov 2 N sentence examples within single molecule array
This study aimed to develop a highly sensitive SARS-CoV-2 nucleocapsid antigen assay using the single molecule array (Simoa) technology and compare it with real time RT-PCR as used in routine clinical practice with the ambition to achieve a comparative technical and clinical sensitivity.
Full Text
Background: This study aimed to develop a highly sensitive SARS-CoV-2 nucleocapsid antigen assay using the single molecule array (Simoa) technology and compare it with real time RT-PCR as used in routine clinical practice with the ambition to achieve a comparative technical and clinical sensitivity.
Full Text
Sars Cov 2 N sentence examples within post symptom onset
Methods: We used serum samples from a pre-COVID era patient cohort (n = 50, pre-December 2019), designated SARS-CoV-2 negative, and serum samples from a SARS-CoV-2 RT-PCR-positive cohort (n = 90) taken > 14 days post-symptom onset (April–May 2020).
Full Text
Sars Cov 2 N sentence examples within chemiluminescent microparticle immunoassay
A chemiluminescent microparticle immunoassay (CMIA) will be used for the qualitative detection of IgG antibodies against SARS-CoV-2 nucleocapsid protein.
Full Text
Methods Presence of immunoglobulin G (IgG) antibody specific to SARS-CoV-2 nucleoprotein was detected using a chemiluminescent microparticle immunoassay in samples from 7,370 patients, without previous history of COVID-19 diagnosis, suspected of having either Dengue (n = 1,700) or Chikungunya (n = 7,349) from December 1st, 2019 to June 30th, 2020.
Full Text
Sars Cov 2 N sentence examples within 14 3 3
Although the association between 14-3-3 and SARS-CoV-2 N proteins can represent one of the key host-pathogen interactions, its molecular mechanism and the specific critical phosphosites are unknown.
Full Text
coli expression system for incorporating nhpSer into target proteins – we show that nhpSer faithfully mimics the effects of phosphoserine in three stringent test cases: promoting 14-3-3/client complexation, disrupting 14-3-3 dimers, and activating GSK3β phosphorylation of the SARS-CoV-2 nucleocapsid protein.
Full Text
Sars Cov 2 N sentence examples within respiratory distress syndrome
The baby developed respiratory distress syndrome requiring endotracheal surfactant administration and nasal-CPAP for one day but nasopharyngeal swabs at birth and after 48 hours were SARS-CoV-2 negative.
Full Text
Out of the four structural proteins of SARS-CoV-2 namely, spike, envelope, nucleocapsid and membrane, envelope protein governs the virus pathogenicity and induction of acute-respiratory-distress-syndrome which is the major cause of death in COVID-19 patients.
Full Text
Sars Cov 2 N sentence examples within protein receptor binding
Among them, COVID-eVax—a DNA plasmid encoding a secreted monomeric form of SARS-CoV-2 S protein receptor-binding domain (RBD)—induced the most potent anti-SARS-CoV-2 neutralizing antibody responses (including against the current most common variants of concern) and a robust T cell response.
Full Text
Total antibody responses to SARS-CoV-2 nucleocapsid (N) and spike protein receptor binding domain (S/RBD) were assessed using commercial immunoassays.
Full Text
Sars Cov 2 N sentence examples within 95 % confidence
In multivariate analysis, SARS-CoV-2 negative conversion within 14 days was 12 times more likely in the ciclesonide group (95% confidence interval, 1.
Full Text
We describe a rapid liquid chromatography/mass spectrometry (LC/MS) method for the direct detection and quantitation of SARS-CoV-2 nucleoprotein in gargle solutions and saliva.
Full Text
One hundred and twenty-two patients were initially identified who resulted SARS-CoV-2 nasopharyngeal RT-PCR swab positivity with any electroencephalography order placed in the EMR.